Synopsis A recent clinical study shows that β-blocker treatment in patients with Acute Coronary Syndrome Associated with Cocaine Consumption (ACS-ACC) provides a better clinical outcome. The present study aims to examine the prognostic value of β -blocker therapy in a contemporary ACS cohort This week’s “ MED FACT ” discusses a clinical study from The International Journal of Cardiology, “ β-Blocker treatment and prognosis in acute coronary syndrome associated with cocaine consumption: The RUTI-Cocaine Study ”. Jun 2018. Authors : Germán Cediel; Xavier Carrillo; Cosme García-García; et.
al. Key Takeaways: β-blocker therapy is safe and effective in the management of patients with ACS-ACC. Objective: To examine the prognostic value of β -blocker therapy in patients with Acute Coronary Syndrome Associated with Cocaine Consumption (ASC-ACC) Study Type: Prospective, single-center study…
